See the DrugPatentWatch profile for lipitor

Based on the information available, there have been some changes in the insurance coverage for Lipitor, a popular cholesterol-lowering drug.

Lipitor, also known as atorvastatin, is a statin medication that has been widely used to treat high cholesterol levels. However, the patent for Lipitor expired in 2011, which led to the introduction of generic versions of the drug [1].

With the availability of generic atorvastatin, many insurance companies have changed their coverage policies to favor the use of generics over the brand-name Lipitor. This means that patients may face higher out-of-pocket costs when choosing the brand-name drug over the generic equivalent [2].

However, it is important to note that the coverage and cost-sharing for Lipitor and its generics can vary depending on the specific insurance plan and the pharmacy benefit manager (PBM) used by the plan [3]. Therefore, patients are encouraged to check with their insurance providers to understand their specific coverage and cost-sharing for Lipitor and its generics.

In summary, while the patent expiration of Lipitor has led to changes in insurance coverage favoring generic atorvastatin, the specific coverage and cost-sharing can vary depending on the insurance plan and PBM.

Sources:
[1] <https://www.drugpatentwatch.com/patent/Lipitor-Atorvastatin-Calcium-Tablets-Pfizer-US-6713397-2011-06-11/>
[2] <https://www.healthline.com/health/high-cholesterol/lipitor-cost#generic-options>
[3] <https://www.goodrx.com/lipitor>